Novel myostatin-specific antibody enhances muscle strength in muscle disease models
Abstract Myostatin, a member of the transforming growth factor-β superfamily, is an attractive target for muscle disease therapy because of its role as a negative regulator of muscle growth and strength. Here, we describe a novel antibody therapeutic approach that maximizes the potential of myostati...
Main Authors: | Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Ken Ohmine, Meiri Shida-Kawazoe, Rie Miyano-Nishizawa, Yuichiro Shimizu, Momoko Okuda, Yuji Hori, Madoka Hayashi, Kenta Haraya, Nobuhiro Ban, Tatsuya Nonaka, Masaki Honda, Hidetomo Kitamura, Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa, Yoshiki Kawabe, Junichi Nezu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-81669-8 |
Similar Items
-
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody.
by: Zenjiro Sampei, et al.
Published: (2018-01-01) -
The role of myostatin in skeletal muscle development
by: YU-CHUAN LIANG, et al.
Published: (2006) -
Effect of myostatin inhibitor on smooth muscle regeneration
by: S. Salemi, et al.
Published: (2020-07-01) -
The role of myostatin during avian muscle development
by: Amthor, Helge
Published: (2007) -
The Regulation of Myostatin and Its Relationship with Muscle Atrophy
by: Der-Sheng Han, et al.
Published: (2011)